Overexpression of the Naturally Occurring bla OXA-51 Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence IS Aba9

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

Resistance to carbapenems in Acinetobacter baumannii is increasingly reported and is mostly associated with expression of carbapenemases, most frequently carbapenem-hydrolyzing class D β-lactamases. Four major subgroups exist in A. baumannii: naturally occurring OXA-51/69-type and acquired OXA-23, OXA-24/40, OXA-58-type β-lactamases. OXA-51/69 might contribute to resistance via ISAba1 insertion in its promoter region. Twenty nonrepetitive carbapenem-resistant A. baumannii clinical isolates were studied. All were resistant to imipenem (8 additionally to meropenem, MICs 8-64 μg/ml). No metallo-β-lactamase production was detected. PFGE revealed 5 distinct clones (I-V). PCR showed 16 isolates (clones I-III) had blaOXA-58; none had blaOXA-23/40; all had blaOXA-51. In isolate Ab5, ISAba1 upstream of blaOXA-51 was truncated by novel insertion sequence ISAba9 (974 bp, IS982 family, 17-bp inverted repeats, 8-bp target site duplication TTGTTTAA). A hybrid promoter (35 box in ISAba9, 10 box in ISAba1, optimal 17-bp spacing) was identified. Quantitative RT-PCR showed 8-fold higher blaOXA-51 expression in Ab5 (ISAba1+ISAba9) vs clonally related Ab2 (ISAba1 alone). PCR screening found ISAba9 in 4 isolates but only upstream of blaOXA-51 in Ab5. In conclusion, novel ISAba9 is involved in blaOXA-51 gene overexpression, contributing to carbapenem resistance in A. baumannii.

Knowledge Graph

Similar Paper

Overexpression of the Naturally Occurring bla <sub>OXA-51</sub> Gene in Acinetobacter baumannii Mediated by Novel Insertion Sequence IS Aba9
Antimicrobial Agents and Chemotherapy 2009.0
ISAba825, a Functional Insertion Sequence Modulating Genomic Plasticity and bla <sub>OXA-58</sub> Expression in Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2011.0
Carbapenem-Resistant Acinetobacter baumannii Isolates from Tunisia Producing the OXA-58-Like Carbapenem-Hydrolyzing Oxacillinase OXA-97
Antimicrobial Agents and Chemotherapy 2008.0
Emergence and Distribution of Plasmids Bearing the bla <sub>OXA-51</sub> -Like Gene with an Upstream IS Aba1 in Carbapenem-Resistant Acinetobacter baumannii Isolates in Taiwan
Antimicrobial Agents and Chemotherapy 2010.0
In Vivo Selection of Reduced Susceptibility to Carbapenems in Acinetobacter baumannii Related to IS Aba1 -Mediated Overexpression of the Natural bla <sub>OXA-66</sub> Oxacillinase Gene
Antimicrobial Agents and Chemotherapy 2009.0
Acquisition of a Plasmid-Borne bla <sub>OXA-58</sub> Gene with an Upstream IS 1008 Insertion Conferring a High Level of Carbapenem Resistance to Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2008.0
A Plasmid-Borne bla <sub>OXA-58</sub> Gene Confers Imipenem Resistance to Acinetobacter baumannii Isolates from a Lebanese Hospital
Antimicrobial Agents and Chemotherapy 2008.0
Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania
Antimicrobial Agents and Chemotherapy 2008.0
Genetic Basis of Multidrug Resistance in Acinetobacter Clinical Isolates in Taiwan
Antimicrobial Agents and Chemotherapy 2010.0
Contribution of a Plasmid-Borne bla <sub>OXA-58</sub> Gene with Its Hybrid Promoter Provided by IS 1006 and an IS Aba3 -Like Element to β-Lactam Resistance in Acinetobacter Genomic Species 13TU
Antimicrobial Agents and Chemotherapy 2010.0